July 6, 2026 · For Immediate Release
Pastør21 AI Assessed “Awardable” for DARPA ERIS Marketplace
SAN DIEGO, CA — July 6, 2026 —
Pastør21 AI, a leading provider of explainable-AI genomic-intelligence software for pathogen surveillance and biothreat attribution, announced that it has achieved “awardable” status through the DARPA Expedited Research Innovation System (ERIS) Marketplace. Achieving awardable status readies the company’s explainable-AI genomic platform for defense and biothreat attribution missions.
Pastør21 AI’s solutions are designed to transform global genomic data into precise, field-deployable pathogen identification and biothreat attribution. “Achieving awardable status in the ERIS Marketplace means our platform is ready to move from competitive assessment to real mission impact,” said Jonathan Monk, Co-Founder and CTO of Pastør21 AI. “It puts precise, field-deployable pathogen surveillance and attribution directly in front of the government customers who need it — telling them not just what a pathogen is, but what it can do and where it came from.”
Pastør21 AI’s video, “Building a High-Resolution Global Pangenome Database for Rapid Surveillance and In-Field Diagnosis,” accessible only by government customers with a .mil email address on the DARPA ERIS Marketplace, presents an actual use case in which the company decomposes pathogen pangenomes into “phylons” — sets of co-occurring genes that define closely related strain subgroups — to generate unique DNA-marker signatures for rapid in-field diagnosis and biothreat attribution.
Government customers interested in viewing the video solution can create an ERIS Marketplace account at www.darpaconnect.us/eris.
About Pastør21 AI
Pastør21 AI builds explainable-AI genomic-intelligence software that turns global pangenomic data into actionable surveillance, diagnostics, and biothreat attribution for national security and public health. Its platform operates on edge devices even without network connectivity and is validated against a worldwide pipeline of clinical isolates annotated with treatment and outcome histories.
Media contact: media@p21ai.com, Pastør21 AI, Inc., p21ai.com